The more recent cases of COVID-19 seem to be coming from homes and family contacts, rather than from strangers. And there, with the "opening up" of social mobility, is an increasing interest in the spread and dispersion of airborne COVID-19 particles. There are lessons to be learned from atmospheric science, especially when it pertains to the dispersion of small particles.
Disease
Are bald men more likely to get severe COVID-19? There are more than 30,000 news stories about this, almost all of which without question, accept the findings of a flawed epidemiological study from Spain. Is this a valid conclusion? Let's ask a biostatistician.
Making life or death decisions has been brought into sharp relief by the COVID-19 pandemic. For the estimated 500,000 people on dialysis in the U.S., that is a bridge already crossed. Having chosen a life requiring continuous life support, do any of them have second thoughts?
"The COVID-19 pandemic has made brutally clear the need for further research into many aspects of viruses. In this article, we compile data about the basic properties of the SARS-CoV-2 virus, and about how it interacts with the body." Image from Science Forum: SARS-CoV-2 (COVID-19) by the numbers eLIfe
Perhaps you've noticed: Hospitals are asking you to come back for your routine care. Amongst the surge in caring for COVID-19 patients, elective care, especially remunerative procedural care, was pushed to the sidelines. One source suggests that overall cancer care has decreased by 37% during the pandemic.
Royce Chen, M.D., an ophthalmologic surgeon at NY-Presbyterian Hospital, was looking at far more than eyes once the COVID-19 pandemic hit New York. He and other physicians were redeployed to the ICU to help care for the new influx of patients. His article addresses an interesting question - which specialties were hardest hit? And how did physicians in the New York area feel about the PPE provided for them? (Hint: not so good.)
Currently, COVID-19 vaccines are all the rage. Expectations are not only high, they are too high. ACSH friend, and former trustee, Dr. Paul Offit gives us a much-needed reality check. A vaccine, especially a very effective one, is unlikely to be in the cards anytime soon. Although it is always better to prevent an infection than treat one, antiviral drugs are likely to be the tools to control coronavirus well before a vaccine appears.Here's how Dr. Offit sees this playing out.
The COVID-19 lockdown is responsible for both the loss of economic activity and human lives. Two independent groups of researchers concluded that the lockdown may be costing more lives than it saves.
Throughout the coronavirus crisis, the co-authors of this article have often held opposite viewpoints on many aspects of the issue. Despite coming from different disciplines with competing perspectives, they join forces to address puzzling questions about coronavirus mortality statistics.
Like many inveterate news junkies, I’ve had it with COVID-19 case and death counts and flattening of curves. The U.S. has seven times as many COVID-19 cases as European countries but five times the population. The relevant figures are thus 0.5% and about 0.3% of the population, respectively. New cases are dropping in the Eastern U.S. but not in the west. What’s going on?
Another “novel” feature of COVID-19 is coming to our attention: some individuals are more capable than others of sharing their viral load and infecting others. What’s up with that? Let's take a look.
The most general advice physicians give to patients is this: watch your weight, exercise, drink if you must (but only in moderation) and don’t smoke. Turns out, given the current value put on a quality year of life, that advice is worth almost a million bucks. Here's why.